New retinal nerve cells and how they affect vision
Unique physiological properties of novel ganglion cell types in primate retina
Researchers are learning how four little-known retinal cell types in primates process visual information to help develop future treatments for people with vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11302713 on NIH RePORTER |
What this research studies
From a patient's point of view, the team studies cells from the macaque (primate) retina to understand how those cells respond to light, motion, and contrast. They record electrical signals from identified ganglion and amacrine cells and map each cell type's receptive fields and timing. The work examines how A1 amacrine cell activity shapes parasol ganglion responses, why broad thorny ganglion cells have unusual spatial and temporal reactions, and how ON- and OFF-type smooth monostratified ganglion cells carry different signals. The goal is to translate these circuit-level findings into ideas that could improve therapies or devices aimed at restoring vision.
Who could benefit from this research
Good fit: Patients who might benefit from future therapies based on this work include adults with retinal degenerations or other retinal causes of vision loss who are eligible for retina-targeted treatments.
Not a fit: People whose vision loss is due to non-retinal causes (for example, optic nerve or brain injury) or those without visual impairment are unlikely to see direct benefit from this basic lab research.
Why it matters
Potential benefit: If successful, the project could reveal key retinal circuit mechanisms that inform more precise vision-restoring therapies or retinal prosthetic designs.
How similar studies have performed: Previous physiology studies in non-primate animals have successfully mapped many retinal circuits, but applying those findings to primate retina and human therapies remains relatively novel.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Chichilnisky, Eduardo — Stanford University
- Study coordinator: Chichilnisky, Eduardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.